Novartis AG (NVS)

NYSE • Currently up 0.08 (+0.06%) in today's trading session

11 members of Congress have disclosed 75 trades in Novartis AG (NVS) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 31 October 2025. The most active traders have been Donald S. Beyer (35), Lisa McClain (10), and John H. Rutherford (7). Aggregate disclosed activity totals roughly $280K in purchases and $447K in sales (midpoint estimates from bracketed disclosure amounts).

Novartis AG is currently trading at $138.70, positioned at 35% of its 52-week range ($121.57 – $170.46).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$138.70
24h Change
+0.08 (+0.06%)
52 Week Range
$121.57–$170.46
View on NASDAQ

Novartis AG Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for NVS

Select to highlight on chart
5 transactions
Compliance: 49%
Lisa McClain31 Oct 202521 Nov 2025SaleStock$1,001 - $15,000N/A
Lisa McClain30 Oct 202521 Nov 2025SaleStock$1,001 - $15,000N/A
Lisa McClain30 Oct 202521 Nov 2025PurchaseStock$1,001 - $15,000+13.88%
Lisa McClain25 Sept 202522 Oct 2025SaleStock$1,001 - $15,000N/A
Lisa McClain11 Sept 202522 Oct 2025PurchaseStock$1,001 - $15,000+13.25%

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$263.63B

Volume

1.89M

Beta

0.46

P/E Ratio

15.96

Fundamentals

EPS

$8.69

Div. Yield

3.42%

Open

$140.58

Day Range

$138.28 – $141.46

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE · USD
Country
CH
CEO
Vasant Narasimhan
IPO Date
1996-11-07
Website
www.novartis.com

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscie...

Earnings

Next Report

Q3 2026

27 Oct

EPS Est.

$2.24

Rev. Est.

$14.6B

Days Until

41

Recent Quarters

Q2 202621 Jul
EPS$2.41
Beat 11.1%
Q1 202628 Apr
EPS$1.99
Miss 5.7%
Q4 20254 Feb
EPS$2.03
Beat 2.0%
Q3 202528 Oct
EPS$2.25
Miss 0.4%
Q2 202517 Jul
EPS$2.42
Beat 1.7%
Q1 202529 Apr
EPS$2.28
Beat 7.5%
Q4 202431 Jan
EPS$1.98
Beat 10.0%
Q3 202429 Oct
EPS$2.06
Beat 6.2%
Q2 202418 Jul
EPS$1.97
Beat 4.2%
Q1 202423 Apr
EPS$1.80
Beat 4.0%
Q4 202331 Jan
EPS$1.53
Miss 6.7%
Q3 202324 Oct
EPS$1.74
Beat 2.4%
Q2 202318 Jul
EPS$1.83
Beat 8.9%
Q1 202325 Apr
EPS$1.71
Beat 10.3%
Q4 20221 Feb
EPS$1.51
Beat 6.3%
Q3 202225 Oct
EPS$1.58
Beat 0.6%
Q2 202219 Jul
EPS$1.56
Beat 3.3%
Q1 202226 Apr
EPS$1.46
Beat 1.4%
Q4 20212 Feb
EPS$1.40
Miss 2.8%
Q3 202126 Oct
EPS$1.71
Beat 3.6%
Q2 202121 Jul
EPS$1.66
Beat 8.5%
Q1 202127 Apr
EPS$1.52
Miss 3.2%
Q4 202026 Jan
EPS$1.34
Miss 2.9%
Q3 202027 Oct
EPS$1.52
Beat 7.0%
Q2 202021 Jul
EPS$1.35
Beat 4.7%
Q1 202028 Apr
EPS$1.55
Beat 13.1%
Q4 201929 Jan
EPS$1.31
Miss 0.8%
Q3 201922 Oct
EPS$1.41
Beat 7.6%
Q2 201918 Jul
EPS$1.32
Beat 10.0%
Q1 201924 Apr
EPS$1.20
Beat 8.1%
Q4 201830 Jan
EPS$1.24
Miss 6.8%
Q3 201818 Oct
EPS$1.31
Beat 0.0%
Q2 201818 Jul
EPS$1.26
Miss 0.8%
Q1 201819 Apr
EPS$1.28
Beat 2.4%
Q4 201724 Jan
EPS$1.20
Beat 3.5%
Q3 201724 Oct
EPS$1.29
Beat 3.2%
Q2 201718 Jul
EPS$1.21
Beat 4.3%
Q1 201725 Apr
EPS$1.13
Beat 2.7%
Q4 201625 Jan
EPS$1.12
Beat 2.8%
Q3 201625 Oct
EPS$1.23
Beat 4.2%
Q2 201619 Jul
EPS$1.22
Beat 3.4%
Q1 201621 Apr
EPS$1.17
Miss 0.8%
Q4 201527 Jan
EPS$1.11
Miss 9.0%
Q3 201527 Oct
EPS$1.27
Miss 3.0%
Q2 201521 Jul
EPS$1.26
Beat 5.0%
Q1 201523 Apr
EPS$1.33
Beat 18.8%
Q4 201427 Jan
EPS$1.21
Beat 7.1%
Q3 201428 Oct
EPS$1.37
Beat 6.2%
Q2 201417 Jul
EPS$1.34
Miss 4.3%
Q1 201424 Apr
EPS$1.28
Miss 3.8%
Q4 201329 Jan
EPS$1.20
Miss 1.6%
Q3 201322 Oct
EPS$1.25
Miss 5.3%
Q2 201317 Jul
EPS$1.30
Beat 0.8%
Q1 201324 Apr
EPS$1.30
Beat 4.0%
Q4 201223 Jan
EPS$1.27
Beat 0.0%
Q3 201225 Oct
EPS$1.34
Miss 2.9%
Q2 201219 Jul
EPS$1.38
Beat 7.0%
Q1 201224 Apr
EPS$1.27
Miss 3.8%
Q4 201125 Jan
EPS$1.23
Beat 2.5%
Q3 201125 Oct
EPS$1.45
Miss 4.0%
Q2 201119 Jul
EPS$1.48
Beat 5.7%
Q1 201119 Apr
EPS$1.41
Beat 7.6%
Q4 201027 Jan
EPS$1.14
Miss 8.8%
Q3 201021 Oct
EPS$1.27
Beat 5.8%
Q2 201015 Jul
EPS$1.20
Beat 6.2%
Q1 201020 Apr
EPS$1.44
Beat 17.1%
Q4 200926 Jan
EPS$1.01
Miss 8.2%
Q3 200922 Oct
EPS$0.92
Miss 3.2%
Q2 200916 Jul
EPS$0.89
Beat 4.7%
Q1 200923 Apr
EPS$0.87
Beat 0.0%
Q4 200828 Jan
EPS$0.66
Miss 16.5%
Q3 200820 Oct
EPS$0.92
Miss 3.2%
Q2 200817 Jul
EPS$0.98
Beat 5.4%
Q1 200821 Apr
EPS$1.02
Beat 14.6%
Q4 200717 Jan
EPS$0.40
Miss 45.2%
Q3 200718 Oct
EPS$0.68
Miss 10.5%
Q2 200717 Jul
EPS$0.83
Beat 6.4%
Q1 200723 Apr
EPS$0.92
Beat 9.5%
Q4 200618 Jan
EPS$0.70
Miss 10.3%
Q3 200619 Oct
EPS$0.79
Beat 4.0%
Q2 200617 Jul
EPS$0.73
Miss 7.6%
Q1 200624 Apr
EPS$0.83
Beat 16.9%
Q4 200519 Jan
EPS$0.58
Miss 18.3%
Q3 200518 Oct
EPS$0.71
Miss 1.4%
Q2 200514 Jul
EPS$0.70
Beat 6.1%
Q1 200530 Jun
EPS$0.70
Q4 200420 Jan
EPS$0.56
Miss 6.7%
Q3 200421 Oct
EPS$0.63
Beat 8.6%
Q2 200420 Jul
EPS$0.63
Beat 6.8%
Q1 200422 Apr
EPS$0.52
Miss 1.9%
Q4 200322 Jan
EPS$0.55
Beat 3.8%
Q3 200320 Oct
EPS$0.52
Beat 0.0%
Q2 200321 Jul
EPS$0.52
Beat 2.0%
Q1 200315 Apr
EPS$0.43
Miss 6.5%
Q4 200223 Jan
EPS$0.45
Beat 7.1%
Q3 200217 Oct
EPS$0.55
Beat 24.3%
Q2 200230 Sept
EPS$0.44
Q4 200131 Mar
EPS$0.43
Q4 200118 Mar
EPS$0.40
Q2 200130 Sept
EPS$0.44
Q1 200130 Jun
EPS$0.40
Q1 200111 Apr
EPS$0.41
Q4 200031 Mar
EPS$0.41
Q2 200030 Sept
EPS$0.33
Q1 200030 Jun
EPS$0.49
Q4 199931 Mar
EPS$0.49
Q4 19981 Jan
EPS-
Q2 19981 Jul
EPS-
Q4 199717 Mar
EPS$0.51
Miss 8.9%
Q2 19972 Sept
EPS$0.79
Beat 0.0%
Q1 199722 Apr
EPS$0.52
Beat 15.6%

20 politicians traded within 30 days

Dividends

Dividend History

11 Mar 2026
Amount $4.7403
12 Mar 2025
Amount $3.9940
7 Mar 2024
Amount $3.1986
9 Mar 2023
Amount $3.4987
8 Mar 2022
Amount $3.3253
4 Mar 2021
Amount $3.1991
3 Mar 2020
Amount $3.0874
4 Mar 2019
Amount $2.5672
6 Mar 2018
Amount $2.6676
1 Mar 2017
Amount $2.4606
24 Feb 2016
Amount $2.4749
2 Mar 2015
Amount $2.5242
27 Feb 2014
Amount $2.4364
26 Feb 2013
Amount $2.2670
27 Feb 2012
Amount $2.2043
24 Feb 2011
Amount $2.1084
2 Mar 2010
Amount $1.7805
24 Feb 2009
Amount $1.5412
26 Feb 2008
Amount $1.3190
6 Mar 2007
Amount $0.9686
28 Feb 2006
Amount $0.8011
1 Mar 2005
Amount $0.8635
24 Feb 2004
Amount $0.7222
4 Mar 2003
Amount $0.6272
21 Mar 2002
Amount $0.4677
22 Mar 2001
Amount $0.4498
14 Nov 2000
Amount $0.9660
12 Apr 2000
Amount $0.4012
21 Apr 1999
Amount $0.4763
21 Apr 1998
Amount $0.4182
16 Apr 1997
Amount $0.3403
26 Feb 1997
Amount $1.5308

Stock Splits

Split History

9 Apr 2019Stock Split
Ratio279:250
11 May 2000Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

JNJ

Johnson & Johnson

77
$267.28+0.08 (+0.03%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
+1 more reason
2 politicians
View Stock

JPM

JPMorgan Chase & Co.

49
$348.92-3.57 (-1.01%)
Financial Services
2 politicians both hold this
Significant holdings value
2 politicians
View Stock

EMR

Emerson Electric Co.

47
$145.83-1.17 (-0.80%)
Industrials
2 politicians both hold this
Significant holdings value
2 politicians
View Stock

Frequently Asked Questions about NVS

Which members of Congress have traded NVS?
11 members of Congress have disclosed 75 trades in Novartis AG (NVS) under the STOCK Act. The most active traders are Donald S. Beyer, Lisa McClain, and John H. Rutherford.
When was NVS most recently disclosed by Congress?
The most recent NVS disclosure was a sale by Lisa McClain on 31 October 2025.
What is the total disclosed congressional trading volume for NVS?
Members of Congress have disclosed approximately $280K in NVS purchases and $447K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in NVS?
This NVS page updates as soon as new STOCK Act disclosures are filed for Novartis AG. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.